2023 - Experiences with a Rapid Multiplex NAT System for Bloodstream Infections at a Tertiary Cancer Center

Bloodstream infections can be detrimental to all patient populations, however, in certain patient populations, such as cancer patients, there is an increased risk for poor outcomes. Identification of the pathogen causing the infection coupled with genotypic resistance markers through a rapid multiplex nucleic acid amplification testing (NAT) system can help guide clinicians with proper therapeutic interventions.
In this webinar, Dr. Melvilí Cintrón will discuss considerations for implementing a rapid multiplex NAT system for identifying pathogens and genotypic resistance profiles in bloodstream infections (ePlex® Blood Culture Identification Panels (BCID). She will also provide an overview on how it was integrated within the microbiology laboratory workflow.
In addition, through some case studies from MSKCC, she will detail how well the molecular rapid diagnostic test performs compared to culture while also highlighting how comprehensive the ePlex BCID Panels are in detecting the pathogens causing bloodstream infections.